CVS Health Corporation (CVS)
The price, the headline numbers and the latest news, in one place.
CVS Health Corporation (CVS) Stock Price, Analysis & Data
| Bid | 93.18 |
| Market Cap | 119.02B |
| Revenue (ttm) | 412.64B |
| Net Income (ttm) | 4.89B |
| 0.60 | |
| 3.79 | |
| 24.55 | |
| 10.94 | |
| P/B (ttm) | 1.49 |
| P/S (ttm) | 0.29 |
| Earnings Date | Oct 28, 2026 |
| Ask | 93.14 |
| Volume | 3,992,593 |
| Avg. Volume (20D) | 8,015,392 |
| Open | 93.40 |
| Previous Close | 92.92 |
| Day's Range | 93.02 - 93.93 |
| 52-Week Range | 69.51 - 110.68 |
| Analyst | Strong Buy |
| Price Target | 116 (24.65%) |
| Dividends | $2.66 (2.86%) |
| Ex-Dividend Date | Jul 23, 2026 |
About CVS
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer...
Financial Performance
In 2025, CVS Health's revenue was 402.07B, an increase of 7.85% compared to the previous year's 372.81B. Earnings were 1.77B, a decrease of -61.68%.
Financial StatementsAnalyst Forecast
According to 25 analyst ratings, the average rating for CVS stock is "Strong Buy". The 12-month stock price forecast is 116, which is upside of 24.65% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $106.1B misses estimates by $0, with 7.26% YoY growth.
- EPS of 2.58 exceeds estimates by 0.73, with 42.54% YoY growth.
Analysts project revenue of ... Upgrade
